Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, posted on X about recent paper he and his colleagues co-authored:
“Check out our comprehensive review on AML from an MD Anderson Cancer Center perspective, published in ACS Journal Cancer.
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges.”
Authors: Jayastu Senapati, Hagop Kantarjian, et al.
More posts featuring Hagop Kantarjian.